Remegen
IPO荣昌生物制药（烟台）股份有限公司_荣昌生物
Yantai, China · Founded 2008 · $100.0M raised
- Headquarters
- Yantai
- Founded
- 2008
- Business Model
- B2B
- Website
- remegen.cn
- Total Funding
- $100.0M
- Last Round
- $100.0M Private EquityMar 2020
- Rounds
- 1
About
Fully-integrated Chinese biopharmaceutical company developing innovative oncology therapeutics.
Summary
Remegen is a Biotech company based in Yantai, China, founded in 2008. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Mar 2020. Investors include Lilly Asia Ventures and Lake Bleu Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company